Hormonersatztherapie (HET) für Frauen die bereits wegen eines Endometriumkarzinoms behandelt wurden https://t.co/J7aS4VEkhC
@Doctor_IMF @UpYerBumCharity There’s: https://t.co/q5sADUEErl which basically says we don’t know it’s down to an individual’s priorities.
Limited, very-low certainty, evidence suggests HRT may have little or no effect on the risk of endometrial cancer recurrence in surgically treated women for an early-stage endometrial cancer. No data on whether HRT had an effect on overall survival. https:
RT @Cochrane_GNOCG: On the 16th day of advent …. https://t.co/cSEtfARhSL Bringing you a run-down of our 2018 reviews & protocols in our Co…
On the 16th day of advent …. https://t.co/cSEtfARhSL Bringing you a run-down of our 2018 reviews & protocols in our Cochrane GNOC evidence advent calendar…… #CGNOCadvent18 @CochraneLibrary @CochraneUK @cochrancollab
RT @Cochrane_GNOCG: On the 16th day of advent …. https://t.co/cSEtfARhSL Bringing you a run-down of our 2018 reviews & protocols in our C…
RT @Cochrane_GNOCG: On the 16th day of advent …. https://t.co/cSEtfARhSL Bringing you a run-down of our 2018 reviews & protocols in our C…
On the 16th day of advent …. https://t.co/cSEtfARhSL Bringing you a run-down of our 2018 reviews & protocols in our Cochrane GNOC evidence advent calendar…… #CGNOCadvent18 @CochraneLibrary @CochraneUK @cochrancollab https://t.co/vM3fFTFgt2
RT @Cochrane_GNOCG: Hormone replacement therapy (HRT) for women previously treated for endometrial cancer | Cochrane https://t.co/ylztfBReJ2
RT @Cochrane_GNOCG: Hormone replacement therapy (HRT) for women previously treated for endometrial cancer | Cochrane https://t.co/ylztfBReJ2
RT @Cochrane_GNOCG: Hormone replacement therapy (HRT) for women previously treated for endometrial cancer | Cochrane https://t.co/ylztfBReJ2
@WombCancerUK No good evidence to support withholding so challenge- HRT https://t.co/ylztfBReJ2
Hormone replacement therapy (HRT) for women previously treated for endometrial cancer | Cochrane https://t.co/ylztfBReJ2
RT @ChristieLibrary: Hormone replacement therapy for women previously treated for endometrial cancer @CochraneLibrary Review of 1 study (n=…
Hormone replacement therapy for women previously treated for endometrial cancer @CochraneLibrary Review of 1 study (n=1,236) concludes that there is insufficient high‐quality evidence to inform women considering HRT after treatment for endometrial cancer.
¿Has visto la revisión Cochrane sobre la terapia hormonal sustitutiva en pacientes con antecedente de cáncer de endometrio? https://t.co/yuTr8DIACm https://t.co/yuTr8DIACm
RT @ChristieLibrary: Hormone replacement therapy for women previously treated for endometrial cancer @CochraneLibrary There is insufficient…
Hormone replacement therapy for women previously treated for endometrial cancer @CochraneLibrary There is insufficient high-quality evidence to inform women considering HRT after treatment for endometrial cancer. Evidence does not suggest significant harm
Hormone replacement therapy (HRT) for women previously treated for #wombcancer https://t.co/7X5AiUmdSU